← Back to Search

ICG injection group for Lung Cancer

Phase 1

Waitlist Available

Led By Sunil Singhal, MD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 day after injection of icg

Awards & highlights

All Individual Drugs Already Approved

No Placebo-Only Group

Summary

Our specific aim is to determine if Indocyanine Green (ICG) administered intraoperatively and imaged using our camera will aid in the identification of a suspected lung nodule.

Eligible Conditions

Lung Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 day after injection of icg

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 day after injection of icg

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day after injection of icg for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Imaging effectiveness of ICG and imaging system.

Awards & Highlights

All Individual Drugs Already Approved

Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: ICG injection groupExperimental Treatment1 Intervention

This group will receive a single dose of ICG, diluted in saline solution, prior to surgery. Then, during their surgery, they will be imaged with the camera and imaging probe we have developed.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Indocyanine green

FDA approved

Do I qualify?Apply below to find out